Ctsktm1(cre)Ska/Ctsk+
Esr1tm1Mma/Esr1tm1Mma
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal osteoclast physiology |
J:127179
|
|
decreased bone mineral density of femur |
J:127179
|
|
increased bone mineralization |
J:127179
|
|
increased bone ossification |
J:127179
|
|
increased bone resorption |
J:127179
|
|
increased osteoclast cell number |
J:127179
|
|
osteoporosis |
J:127179
|
Esr1tm1.1(cre)And/Esr1+
B6.129S6(Cg)-Esr1tm1.1(cre)And
|
abnormal social investigation |
J:207677
|
|
decreased aggression towards mice |
J:207677
|
|
increased aggression towards mice |
J:207677
|
Esr1tm1.1Gust/Esr1tm1.1Gust
B6.129X1-Esr1tm1.1Gust
|
abnormal mammary gland development |
J:186230
|
|
absent corpus luteum |
J:186230
|
|
absent mature ovarian follicles |
J:186230
|
|
female infertility |
J:186230
|
|
increased body weight |
J:186230
|
|
increased circulating glucose level |
J:186230
|
|
male infertility |
J:186230
|
|
obese |
J:186230
|
|
ovary cyst |
J:186230
|
|
ovary hemorrhage |
J:186230
|
|
uterus hypoplasia |
J:186230
|
Esr1tm1.1Ics/Esr1tm1.1Ics
involves: C57BL/6NTac
|
abnormal cell migration |
J:206373
|
|
abnormal ovary morphology |
J:206373
|
|
abnormal tertiary ovarian follicle morphology |
J:206373
|
|
abnormal vascular endothelial cell physiology |
J:206373
|
|
abnormal vasodilation |
J:206373
|
|
absent corpus luteum |
J:206373
|
|
decreased circulating progesterone level |
J:206373
|
|
decreased primordial ovarian follicle number |
J:206373
|
|
female infertility |
J:206373
|
|
increased circulating follicle stimulating hormone level |
J:206373
|
|
increased circulating luteinizing hormone level |
J:206373
|
|
ovarian follicular cyst |
J:206373
|
|
ovary hemorrhage |
J:206373
|
|
normal
reproductive system phenotype |
J:206373
|
Esr1tm1.1Lja/Esr1+
involves: 129P2/OlaHsd * 129X1/SvJ
|
abnormal branching of the mammary ductal tree |
J:79228
|
|
abnormal ovary morphology |
J:79228
|
|
abnormal tertiary ovarian follicle morphology |
J:79228
|
|
abnormal uterus physiology |
J:79228
|
|
absent corpus luteum |
J:79228
|
|
decreased circulating progesterone level |
J:79228
|
|
decreased ovulation rate |
J:79228
|
|
endometrium hyperplasia |
J:79228
|
|
enlarged endometrial glands |
J:79228
|
|
enlarged uterus |
J:79228
|
|
female infertility |
J:79228
|
|
increased uterus weight |
J:79228
|
|
uterus cyst |
J:79228
|
Esr1tm1.1Lja/Esr1+
involves: 129P2/OlaHsd * 129X1/SvJ * C57BL/6
|
abnormal bone structure |
J:128135
|
|
decreased areal bone mineral density |
J:128135
|
|
decreased bone mass |
J:128135
|
|
decreased compact bone area |
J:128135
|
|
decreased compact bone thickness |
J:128135
|
|
decreased volumetric bone mineral density |
J:128135
|
|
increased uterus weight |
J:128135
|
|
increased volumetric bone mineral density |
J:128135
|
|
short femur |
J:128135
|
Esr1tm1.1Lja/Esr1tm1.1Mma
involves: 129P2/OlaHsd * 129S2/SvPas * 129X1/SvJ * C57BL/6
|
abnormal bone mineralization |
J:128135
|
|
abnormal bone structure |
J:128135
|
|
abnormal osteoclast physiology |
J:128135
|
|
abnormal volumetric bone mineral density |
J:128135
|
|
decreased bone mass |
J:128135
|
|
decreased circulating insulin-like growth factor I level |
J:128135
|
|
decreased compact bone area |
J:128135
|
|
decreased compact bone thickness |
J:128135
|
|
decreased uterus weight |
J:128135
|
|
decreased volumetric bone mineral density |
J:128135
|
|
increased circulating estradiol level |
J:128135
|
|
short femur |
J:128135
|
Esr1tm1.1Mma/Esr1tm1.1Mma
involves: 129S2/SvPas
|
abnormal vasodilation |
J:206373
|
Esr1tm1.1Mma/Esr1tm1.1Mma
involves: 129S2/SvPas * C57BL/6
|
abnormal bone marrow cell physiology |
J:171276
|
|
abnormal bone mineralization |
J:128135
|
|
abnormal immunoglobulin level |
J:171276
|
|
abnormal response/metabolism to endogenous compounds |
J:171276
|
|
abnormal skeleton physiology |
J:171276
|
|
abnormal thymus physiology |
J:171276
|
|
normal
behavior/neurological phenotype |
J:72240
|
|
decreased uterus weight |
J:128135
|
|
decreased vertical activity |
J:72240
|
|
decreased volumetric bone mineral density |
J:128135
|
|
increased circulating estradiol level |
J:171276
|
|
increased circulating luteinizing hormone level |
J:171276
|
|
increased circulating testosterone level |
J:171276
|
|
increased volumetric bone mineral density |
J:128135
|
|
obese |
J:72240
|
|
normal
reproductive system phenotype |
J:105626
|
Esr1tm1.1Mma/Esr1tm1.1Mma
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal ovarian folliculogenesis |
J:64426
|
|
abnormal ovary morphology |
J:64426
|
|
abnormal response/metabolism to endogenous compounds |
J:64426
|
|
abnormal rete testis morphology |
J:64426
|
|
abnormal seminiferous tubule morphology |
J:64426
|
|
absent corpus luteum |
J:64426
|
|
absent estrous cycle |
J:64426
|
|
decreased male germ cell number |
J:64426
|
|
female infertility |
J:64426
|
|
increased atretic ovarian follicle number |
J:64426
|
|
ovarian follicular cyst |
J:64426
|
|
uterus hypoplasia |
J:64426
|
|
vagina hypoplasia |
J:64426
|
Esr1tm1.1Ohl/Esr1tm1.1Ohl
involves: 129S2/SvPas
|
normal
cardiovascular system phenotype |
J:206373
|
Esr1tm1.1Ohl/Esr1tm1.1Ohl
involves: 129S2/SvPas * C57BL/6
|
abnormal bone marrow cell physiology |
J:171276
|
|
abnormal immunoglobulin level |
J:171276
|
|
abnormal response/metabolism to endogenous compounds |
J:171276
|
|
abnormal skeleton physiology |
J:171276
|
|
abnormal thymus physiology |
J:171276
|
|
increased circulating estradiol level |
J:171276
|
|
increased circulating luteinizing hormone level |
J:171276
|
|
increased circulating testosterone level |
J:171276
|
Esr1tm1.1Pws/Esr1tm1.1Pws
involves: C57BL/6 * CBA
|
abnormal reproductive system morphology |
J:163783
|
|
abnormal vascular wound healing |
J:163783
|
Esr1tm1.1Scma/Esr1tm1.1Scma
Lyz2tm1(cre)Ifo/Lyz2+
involves: 129P2/OlaHsd * 129S4/SvJaeSor * C57BL/6
|
abnormal osteoclast physiology |
J:156947
|
|
abnormal skeleton development |
J:156947
|
|
abnormal trabecular bone morphology |
J:156947
|
|
decreased compact bone mass |
J:156947
|
|
increased osteoclast cell number |
J:156947
|
Esr1tm1.2Awo/Esr1tm1.2Awo
Kiss1tm1.1(cre)Uboe/Kiss1+
involves: 129S6/SvEvTac * C57BL/6 * SJL
|
abnormal estrous cycle |
J:167285
|
|
absent corpus luteum |
J:167285
|
|
decreased circulating luteinizing hormone level |
J:167285
|
|
early vaginal opening |
J:167285
|
|
normal
homeostasis/metabolism phenotype |
J:167285
|
|
increased circulating luteinizing hormone level |
J:167285
|
|
ovarian follicular cyst |
J:167285
|
|
ovary cyst |
J:167285
|
|
prolonged diestrus |
J:167285
|
|
normal
reproductive system phenotype |
J:167285
|
Esr1tm1.2Awo/Esr1tm1.2Awo
Tg(Cga-cre)1Awo/0
involves: C57BL/6 * SJL
|
abnormal estrous cycle |
J:152925
|
|
abnormal luteinizing hormone level |
J:152925
|
|
abnormal ovarian follicle morphology |
J:152925
|
|
absent corpus luteum |
J:152925
|
|
decreased circulating luteinizing hormone level |
J:152925
|
|
decreased corpora lutea number |
J:152925
|
|
decreased gonadotroph cell number |
J:152925
|
|
decreased litter size |
J:152925
|
|
female infertility |
J:152925
|
|
increased circulating estradiol level |
J:152925
|
|
increased circulating luteinizing hormone level |
J:152925
|
|
reduced female fertility |
J:152925
|
|
normal
reproductive system phenotype |
J:152925
|
Esr1tm1.2Mma/Esr1tm1.2Mma
Tg(Cga-cre)3Sac/0
involves: 129S2/SvPas * C57BL/6 * C57BL/6J * SJL
|
abnormal estrous cycle |
J:131949
|
|
female infertility |
J:131949
|
|
ovarian follicular cyst |
J:131949
|
Esr1tm1.2Mma/Esr1tm1.2Mma
Tg(Cyp17a1-icre)AJako/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal estrous cycle |
J:151908
|
|
abnormal ovarian follicle number |
J:151908
|
|
abnormal ovary morphology |
J:151908
|
|
abnormal theca cell layer morphology |
J:151908
|
|
decreased circulating luteinizing hormone level |
J:151908
|
|
decreased corpora lutea number |
J:151908
|
|
decreased superovulation rate |
J:151908
|
|
early reproductive senescence |
J:151908
|
|
female infertility |
J:151908
|
|
increased circulating testosterone level |
J:151908
|
|
increased gonadotroph cell number |
J:151908
|
|
increased theca cell number |
J:151908
|
|
oocyte degeneration |
J:151908
|
|
ovary cyst |
J:151908
|
|
ovary hemorrhage |
J:151908
|
|
prolonged diestrus |
J:151908
|
Esr1tm1.2Mma/Esr1tm1.2Mma
Tg(Wnt7a-EGFP/cre)#Bhr/0
involves: 129S2/SvPas * C57BL/6 * SJL
|
abnormal uterine receptivity |
J:167551
|
|
abnormal uterus morphology |
J:167551
|
|
abnormal uterus size |
J:167551
|
Esr1tm1Arnal/Esr1tm1Arnal
involves: C57BL/6
|
abnormal immunoglobulin level |
J:171276
|
|
abnormal response/metabolism to endogenous compounds |
J:144952,
J:171276
|
|
abnormal skeleton physiology |
J:171276
|
|
increased circulating estradiol level |
J:171276
|
|
increased circulating luteinizing hormone level |
J:171276
|
|
increased circulating testosterone level |
J:171276
|
|
increased osteoclast cell number |
J:171276
|
|
infertility |
J:144952
|
Esr1tm1Geog/Esr1tm1Geog
involves: 129X1/SvJ * C57BL/6
|
abnormal mammary gland development |
J:135981
|
|
abnormal response/metabolism to endogenous compounds |
J:135981
|
|
abnormal uterus morphology |
J:135981
|
|
abnormal vagina morphology |
J:135981
|
|
absent corpus luteum |
J:135981
|
|
anovulation |
J:135981
|
|
decreased physiological sensitivity to xenobiotic |
J:135981
|
|
female infertility |
J:135981
|
|
impaired granulosa cell differentiation |
J:135981
|
|
increased body size |
J:135981
|
|
increased body weight |
J:135981
|
|
increased circulating estradiol level |
J:135981
|
|
increased circulating luteinizing hormone level |
J:135981
|
|
increased circulating testosterone level |
J:135981
|
|
increased gonadal fat pad weight |
J:135981
|
|
increased mammary fat pad weight |
J:135981
|
|
increased tertiary ovarian follicle number |
J:135981
|
|
increased theca cell number |
J:135981
|
|
ovarian follicular cyst |
J:135981
|
|
small uterus |
J:135981
|
|
uterus hypoplasia |
J:135981
|
|
vagina hypoplasia |
J:135981
|
Esr1tm1Gsc/Esr1tm1Gsc
Tg(Camk2a-cre)2Gsc/0
involves: 129P2/OlaHsd * C57BL/6 * FVB/N
|
abnormal endometrium morphology |
J:117231
|
|
abnormal luteinizing hormone level |
J:117231
|
|
abnormal ovary morphology |
J:117231
|
|
abnormal theca cell layer morphology |
J:117231
|
|
absent corpus luteum |
J:117231
|
|
absent endometrial glands |
J:117231
|
|
dilated uterus |
J:117231
|
|
endometrium atrophy |
J:117231
|
|
female infertility |
J:117231
|
|
increased tertiary ovarian follicle number |
J:117231
|
|
normal
nervous system phenotype |
J:117231
|
Esr1tm1Ksk/Esr1+
involves: 129P2/OlaHsd
|
abnormal cremaster muscle morphology |
J:112350
|
|
abnormal testis morphology |
J:112350
|
Esr1tm1Ksk/Esr1tm1Ksk
B6.129P2-Esr1tm1Ksk
|
abnormal nociception after inflammation |
J:151022
|
|
normal
adipose tissue phenotype |
J:65806
|
|
normal
behavior/neurological phenotype |
J:65806
|
|
decreased birth weight |
J:65806
|
|
decreased energy expenditure |
J:65806
|
|
hyporesponsive to tactile stimuli |
J:151022
|
|
impaired glucose tolerance |
J:65806
|
|
impaired passive avoidance behavior |
J:65785
|
|
increased body weight |
J:65806
|
|
increased epididymal fat pad weight |
J:65806
|
|
increased inguinal fat pad weight |
J:65806
|
|
increased parametrial fat pad weight |
J:65806
|
|
increased renal fat pad weight |
J:65806
|
|
increased white adipose tissue amount |
J:65806
|
|
increased white fat cell number |
J:65806
|
|
increased white fat cell size |
J:65806
|
|
insulin resistance |
J:65806
|
Esr1tm1Ksk/Esr1tm1Ksk
B6.129P2-Esr1tm1Ksk/J
|
oligozoospermia |
J:147000
|
|
seminiferous tubule degeneration |
J:147000
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd
|
abnormal bone marrow cell number |
J:110923
|
|
abnormal chondrocyte physiology |
J:111108
|
|
abnormal cremaster muscle morphology |
J:112350
|
|
abnormal efferent ductules of testis morphology |
J:60490
|
|
abnormal epididymis epithelium morphology |
J:60490,
J:83231
|
|
abnormal epididymis morphology |
J:60490
|
|
abnormal internal male genitalia morphology |
J:112350
|
|
abnormal long bone epiphyseal plate morphology |
J:111108
|
|
abnormal male reproductive system physiology |
J:83231
|
|
abnormal mammary gland development |
J:64639
|
|
abnormal ovary morphology |
J:64639
|
|
abnormal physiological response to xenobiotic |
J:135833
|
|
abnormal pituitary gland physiology |
J:40607
|
|
abnormal response/metabolism to endogenous compounds |
J:131313,
J:152738
|
|
abnormal skeleton development |
J:111108
|
|
abnormal testis morphology |
J:60490,
J:112350
|
|
abnormal testis weight |
J:83231
|
|
abnormal vagina epithelium morphology |
J:72221
|
|
abnormal vertebrae morphology |
J:111108
|
|
absent corpus luteum |
J:55147,
J:64639
|
|
albuminuria |
J:152738
|
|
anovulation |
J:64639
|
|
normal
cardiovascular system phenotype |
J:163783
|
|
decreased body length |
J:111108
|
|
decreased circulating estradiol level |
J:152738
|
|
decreased circulating prolactin level |
J:64639
|
|
decreased circulating testosterone level |
J:152738
|
|
decreased immature B cell number |
J:110923
|
|
decreased lactotroph cell number |
J:40607
|
|
decreased long bone epiphyseal plate size |
J:111108
|
|
decreased mature B cell number |
J:110923
|
|
decreased physiological sensitivity to xenobiotic |
J:72221
|
|
decreased uterus weight |
J:72221,
J:152738
|
|
dilated efferent ductule of testis |
J:60490,
J:83231,
J:125658
|
|
dilated rete testis |
J:83231,
J:125658
|
|
expanded mesangial matrix |
J:152738
|
|
failure of embryo implantation |
J:108638
|
|
failure of superovulation |
J:55147
|
|
normal
hematopoietic system phenotype |
J:110923
|
|
impaired glucose tolerance |
J:151012
|
|
impaired ovarian folliculogenesis |
J:55147
|
|
increased body weight |
J:72221,
J:152738
|
|
increased circulating estradiol level |
J:72221
|
|
increased circulating glucose level |
J:151012
|
|
increased circulating testosterone level |
J:152738
|
|
insulin resistance |
J:151012
|
|
male infertility |
J:125658
|
|
oligozoospermia |
J:60490
|
|
ovarian follicular cyst |
J:55147,
J:64639,
J:72221
|
|
ovary hemorrhage |
J:55147,
J:64639
|
|
renal glomerulus hypertrophy |
J:152738
|
|
seminiferous tubule degeneration |
J:112350
|
|
short femur |
J:111108
|
|
spermatic granuloma |
J:60490
|
|
uterus hypoplasia |
J:72221
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd * 129S6/SvEvTac
|
dilated seminiferous tubule |
J:84989
|
|
increased circulating estradiol level |
J:84989
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd * C57BL/6
|
abnormal response of heart to induced stress |
J:62353
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd * C57BL/6 * SJL
|
abnormal mammary gland development |
J:54215
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd * C57BL/6J
|
abnormal B cell number |
J:82423
|
|
abnormal bone marrow cell number |
J:82423
|
|
abnormal class switch recombination |
J:82423
|
|
abnormal endometrium morphology |
J:85911
|
|
abnormal epididymis morphology |
J:36658
|
|
abnormal female reproductive system physiology |
J:16338
|
|
abnormal hypothalamus morphology |
J:99716
|
|
abnormal immunoglobulin level |
J:82423
|
|
abnormal innervation |
J:85911
|
|
abnormal kidney physiology |
J:88156
|
|
abnormal lymph node cell ratio |
J:88156
|
|
abnormal maternal nurturing |
J:51468
|
|
abnormal mating receptivity |
J:16338,
J:51468
|
|
abnormal mesonephros morphology |
J:108807
|
|
abnormal ovary morphology |
J:16338
|
|
abnormal pup retrieval |
J:51468
|
|
abnormal response/metabolism to endogenous compounds |
J:82423
|
|
abnormal seminiferous tubule epithelium morphology |
J:36658
|
|
abnormal seminiferous tubule morphology |
J:36658
|
|
abnormal spermatogenesis |
J:36658
|
|
abnormal spleen physiology |
J:88156
|
|
abnormal uterus morphology |
J:85911
|
|
absent corpus luteum |
J:16338
|
|
asthenozoospermia |
J:36658
|
|
cortical renal glomerulopathies |
J:88156
|
|
decreased aggression |
J:38600
|
|
decreased aggression towards male mice |
J:66582
|
|
decreased areal bone mineral density |
J:62222
|
|
decreased body weight |
J:62222
|
|
decreased bone mineral content |
J:62222
|
|
decreased bone mineral density of femur |
J:62222
|
|
decreased bone mineralization |
J:91765
|
|
decreased bone ossification |
J:91765
|
|
decreased bone strength |
J:62222
|
|
decreased CD4-positive, alpha-beta T cell number |
J:110416
|
|
decreased CD8-positive, alpha-beta T cell number |
J:110416
|
|
decreased circulating insulin-like growth factor I level |
J:62222,
J:114164
|
|
decreased circulating osteocalcin level |
J:62222
|
|
decreased compact bone area |
J:62222
|
|
decreased femoral compact bone area |
J:62222
|
|
decreased heart weight |
J:62222
|
|
decreased length of long bones |
J:114164
|
|
decreased lung weight |
J:62222
|
|
decreased osteoblast cell number |
J:91765
|
|
decreased testis weight |
J:16338,
J:36658
|
|
decreased uterus weight |
J:114164
|
|
detached sperm flagellum |
J:36658
|
|
dilated rete testis |
J:36658
|
|
dilated seminiferous tubule |
J:36658
|
|
failure of ejaculation |
J:38600,
J:66582
|
|
female infertility |
J:16338
|
|
glomerulonephritis |
J:88156
|
|
hyperactivity |
J:38600
|
|
impaired fertilization |
J:36658
|
|
increased aggression towards female mice |
J:51468
|
|
increased anti-double stranded DNA antibody level |
J:88156
|
|
increased body weight |
J:114164
|
|
increased circulating cholesterol level |
J:66077
|
|
increased circulating estradiol level |
J:112080
|
|
increased circulating HDL cholesterol level |
J:66077
|
|
increased circulating leptin level |
J:66077
|
|
increased circulating testosterone level |
J:36658
|
|
increased compact bone area |
J:91765
|
|
increased double-positive T cell number |
J:110416
|
|
increased gonadal fat pad weight |
J:66077
|
|
increased IgG3 level |
J:88156
|
|
increased plasma cell number |
J:88156
|
|
increased retroperitoneal fat pad weight |
J:66077
|
|
increased spleen germinal center number |
J:88156
|
|
increased total body fat amount |
J:66077
|
|
increased urine protein level |
J:88156
|
|
increased vertical activity |
J:38600
|
|
insulin resistance |
J:66077
|
|
male infertility |
J:36658
|
|
obese |
J:66077
|
|
oligozoospermia |
J:16338,
J:36658
|
|
ovarian follicular cyst |
J:16338
|
|
pup cannibalization |
J:51468
|
|
reduced male fertility |
J:16338
|
|
reduced male mating frequency |
J:36658,
J:38600,
J:51468
|
|
renal glomerular immunoglobulin deposits |
J:88156
|
|
seminiferous tubule degeneration |
J:36658
|
|
short femur |
J:62222,
J:114164
|
|
short tibia |
J:114164
|
|
short ulna |
J:91765
|
|
normal
skeleton phenotype |
J:114164
|
|
small uterus |
J:85911
|
|
teratozoospermia |
J:36658
|
|
thymus hypoplasia |
J:110416
|
|
uterus hypoplasia |
J:16338
|
Esr1tm1Ksk/Esr1tm1Ksk
involves: 129P2/OlaHsd * C57BL/6N
|
abnormal B cell differentiation |
J:63462
|
|
abnormal definitive hematopoiesis |
J:63462
|
|
abnormal thymus physiology |
J:111590
|
|
decreased B cell number |
J:63462
|
|
decreased immature B cell number |
J:63462
|
|
decreased mature B cell number |
J:63462
|
|
decreased thymocyte number |
J:111590
|
|
decreased thymus weight |
J:111590
|
Esr1tm1Sakh/Esr1tm1Sakh
Tg(MMTV-cre)4Mam/?
involves: 129P2/OlaHsd * C57BL/6 * FVB
|
abnormal branching of the mammary ductal tree |
J:124962
|
Esr1tm1Sakh/Esr1tm1Sakh
Tg(Wap-cre)11738Mam/?
involves: 129P2/OlaHsd * C57BL/6 * SJL
|
abnormal branching of the mammary ductal tree |
J:124962
|
|
abnormal lactation |
J:124962
|
|
abnormal mammary gland alveolus morphology |
J:124962
|
|
abnormal mammary gland morphology |
J:124962
|
Esr1tm1Syeh/Esr1tm1Syeh
Tmem163Tg(ACTB-cre)2Mrt/0
involves: 129X1/SvJ * FVB/N
|
abnormal female reproductive system morphology |
J:147191
|
|
abnormal granulosa cell morphology |
J:147191
|
|
abnormal male reproductive system morphology |
J:147191
|
|
abnormal myometrium morphology |
J:147191
|
|
abnormal ovary morphology |
J:147191
|
|
abnormal prostate gland branching morphogenesis |
J:147000
|
|
abnormal prostate gland physiology |
J:147000
|
|
abnormal reproductive system physiology |
J:147191
|
|
absent corpus luteum |
J:147191
|
|
decreased male germ cell number |
J:147000
|
|
decreased primary ovarian follicle number |
J:147191
|
|
decreased primordial ovarian follicle number |
J:147191
|
|
decreased testis weight |
J:147000
|
|
female infertility |
J:147191
|
|
impaired ovarian folliculogenesis |
J:147191
|
|
increased atretic ovarian follicle number |
J:147191
|
|
increased circulating testosterone level |
J:147000
|
|
increased total body fat amount |
J:147191
|
|
male infertility |
J:147000
|
|
obese |
J:147191
|
|
oligozoospermia |
J:147000
|
|
ovary cyst |
J:147191
|
|
seminiferous tubule degeneration |
J:147000
|
|
small testis |
J:147000
|
|
uterus hypoplasia |
J:147191
|
|
vagina hypoplasia |
J:147191
|
Esr1tm2.1(cre)And/Esr1tm2.1(cre)And
involves: C57BL/6
|
no abnormal phenotype detected |
J:101977
|
Esr1tm2.1Gsc/Esr1tm2.1Gsc
involves: 129P2/OlaHsd * C57BL/6
|
abnormal mammary gland development |
J:152849
|
|
female infertility |
J:152849
|
|
ovary hemorrhage |
J:152849
|
|
small uterus |
J:152849
|
Esr1tm2Ksk/Esr1tm2Ksk
involves: C57BL/6
|
increased circulating luteinizing hormone level |
J:118736
|
Esr1tm3.1Ksk/Esr1tm3.1Ksk
involves: 129S6/SvEvTac * C57BL/6
|
abnormal mammary gland development |
J:176459
|
|
abnormal ovarian follicle morphology |
J:176459
|
|
abnormal response/metabolism to endogenous compounds |
J:176459
|
|
absent corpus luteum |
J:176459
|
|
absent estrous cycle |
J:176459
|
|
decreased endometrial gland number |
J:176459
|
|
decreased primordial ovarian follicle number |
J:176459
|
|
increased circulating estradiol level |
J:176459
|
|
increased luteinizing hormone level |
J:176459
|
|
small uterus |
J:176459
|
|
uterus cyst |
J:176459
|
|
uterus hypoplasia |
J:176459
|
Esr1tm4.2Ksk/Esr1tm4.2Ksk
involves: C57BL/6 * C57BL/6NTac * CBA
|
abnormal mammary gland development |
J:191182
|
|
abnormal uterus development |
J:191182
|
|
normal
growth/size/body region phenotype |
J:191182
|
|
increased body weight |
J:191182
|
|
increased bone mineral density |
J:191182
|
|
increased circulating luteinizing hormone level |
J:191182
|
|
increased circulating testosterone level |
J:191182
|
|
increased growth rate |
J:191182
|
|
increased total body fat amount |
J:191182
|
Esr1tm5.1Ksk/Esr1tm5.1Ksk
involves: 129 * C57BL/6
|
abnormal uterus morphology |
J:263739
|
|
absent corpus luteum |
J:263739
|
|
infertility |
J:263739
|
|
testicular atrophy |
J:263739
|
|
uterus hypoplasia |
J:263739
|
Tg(MMTV-rtTA)1Lach/0
Tg(tetO-Esr1)#Paf/0
involves: FVB/N
|
abnormal branching of the mammary ductal tree |
J:96383
|
|
abnormal mammary gland duct morphology |
J:96383
|
|
abnormal mammary gland epithelium morphology |
J:96383
|
|
abnormal mammary gland lobule morphology |
J:96383
|
|
abnormal mammary gland morphology |
J:96383
|
|
increased mammary gland ductal carcinoma incidence |
J:96383
|
|
mammary gland alveolar hyperplasia |
J:96383
|
|
mammary gland duct hyperplasia |
J:96383
|
Tg(MMTVtTA)1Mam/0
Tg(tetO-Esr1)#Paf/0
involves: C57BL/6 * FVB/N * SJL
|
abnormal seminal vesicle morphology |
J:78639
|
|
abnormal vas deferens morphology |
J:78639
|
|
decreased epididymis weight |
J:78639
|
|
decreased litter size |
J:78639
|
|
short estrus |
J:78639
|
Excel File
Analysis Tools